Thus, a promising therapeutic approach for overcoming tumor cell resistance to apoptosis involves inhibiting the anti-apoptotic Bcl2 protein, aligning with novel strategies involved in tumor pathogenesis [52]. Here, BCL2 is linked to neoplasm.